Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXFG7R
|
||||
| Drug Name |
N3-(4-(3-morpholinopropoxy)phenyl)-1-(pyridin-2-yl)-1H-1,2,4-triazole-3,5-diamine
|
||||
| Synonyms |
CHEMBL1835751
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C20H25N7O2
|
||||
| Canonical SMILES |
Nc1nc(Nc2ccc(OCCCN3CCOCC3)cc2)nn1c4ccccn4
|
||||
| InChI |
InChI=1S/C20H25N7O2/c21-19-24-20(25-27(19)18-4-1-2-9-22-18)23-16-5-7-17(8-6-16)29-13-3-10-26-11-14-28-15-12-26/h1-2,4-9H,3,10-15H2,(H3,21,23,24,25)
|
||||
| InChIKey |
NIPJQRGYPGKSQY-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | FL cytokine receptor | Target Info | [1587926] | ||
| Mast/stem cell growth factor receptor | Target Info | [1587926] | |||
| KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
| Hematopoietic cell lineage | |||||
| Pathways in cancer | |||||
| Transcriptional misregulation in cancer | |||||
| Acute myeloid leukemia | |||||
| Central carbon metabolism in cancerhsa04014:Ras signaling pathway | |||||
| Rap1 signaling pathway | |||||
| Endocytosis | |||||
| PI3K-Akt signaling pathway | |||||
| Melanogenesis | |||||
| Central carbon metabolism in cancer | |||||
| Pathway Interaction Database | C-MYB transcription factor network | ||||
| Signaling events mediated by Stem cell factor receptor (c-Kit) | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.